Abstract:At present, praziquantel (PZQ) is the only drug utilized in clinics for the control and treatment of all forms of schistosomiasis, which is a neglected tropical disease infecting over 200 million people. As only the R-isomer of PZQ is biologically active and devoid of associated undesired properties, the development of a stereoselective, sustainable, and cost-effective synthesis of (R)-PZQ is of paramount significance. Herein, a known monoamine oxidase variant, MAO-N-D11D, which showed a specific activity of merely 0.003 U/mg toward 1-cyclohexanecarboxylaminomethyl-tetrahydroisoquinoline (THIQ) (1a), a synthetic intermediate to PZQ, was extensively engineered using combinatorial active-site saturation test/iterative saturation mutagenesis and site-saturation mutagenesis, resulting in the identification of an evolved variant, referred to as LJY-FM, exhibiting 134-fold elevated specific activity (0.401 U/mg) and 260-fold enhanced catalytic efficiency (26,989 min-1 M-1) toward 1a relative to MAO-N-D11D, respectively. After optimizing protein expression and reaction conditions, gram-scale deracemization of 50 mM of 1a catalyzed by variant LJY-FM was executed in the presence of ammonia borane, with (R)-1a, a critical intermediate to (R)-PZQ, being furnished with 76% isolated yield and 96% ee. Subsequent transformation of (R)-1a to (R)-PZQ was achieved in 82% yield. Moreover, eight 1-acylaminomethyl-THIQ derivatives, (R)-1b to (R)-1i, were prepared in 44-99% isolated yields with 90 to >99% ee through a LJY-FM-catalyzed deracemization process. To the best of our knowledge, our work represents the first application of monoamine oxidase to the synthesis of (R)-PZQ or its synthetic intermediates. We expect the efficient, stereoselective, and sustainable synthesis of (R)-PZQ established in the current study to be harnessed for the eventual development of a cost-effective, green production route of this antischistosomal agent, thereby leading to the realization of replacing the clinical use of praziquantel by (R)-praziquantel in the future.

Upscaling and Risk Evaluation of the Synthesis of the 3,5-Diamino-1H-Pyrazole, Disperazol

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Building a Quaternary Stereogenic Center on Dihydroazaindole Carboxylic Acid through Scalable Process Development

Process Development and Scale-Up of a Novel Atypical DAT Inhibitor ( S )-CE-123

A Concise Enantioselective Synthesis of Fluorinated Pyrazolo-Piperidine GSK3901383A Enabled by an Organocatalytic Aza-Michael Addition

Development of a Safe, Efficient, and Scalable Process for the Synthesis of Midazolam Hydrochloride

Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid Through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling

Scalable Synthesis of Antihistamines and Sensipar via Intensified Hydrogen Borrowing Methodology

A Green Synthetic Strategy for Pyrazolo[1,5-a]pyrimidin-7(4H)-one Derivatives by the Reaction of Aminopyrazoles and Symmetric/Non-symmetric Alkynes Assisted by KHSO4 in Aqueous Media

A Streamlined, Safe and Sustainable Process for Gemlapodect

High efficacy treatment of murine Pseudomonas aeruginosa catheter-associated urinary tract infections using the c-di-GMP modulating anti-biofilm compound Disperazol in combination with ciprofloxacin

Practical and Scalable Synthesis of 5,6-Dichlorofurazano[3,4- b ]pyrazine

Engineered Monoamine Oxidase-Catalyzed Deracemization of Sterically Hindered Acylaminomethyl-tetrahydroisoquinoline: Asymmetric Synthesis of (R)-(−)-praziquantel and Its Analogues

A ChemoEnzymatic Approach for the Preparation of "Linear‐Shaped" Diaryl Pyrazines as Potential Antiprotozoal Agents

An integrated approach combining experimental, informatics and energetic methods for solid form derisking of PF-06282999

Umpolung Flow Chemistry for the Synthesis of a 3-Oxo-3 H -spiro[benzofuran-2,4'-piperidine] Building Block

An Improved Synthesis of 2,3-Diamino-5,6-dichloropyrazine: A Useful Heterocyclic Scaffold

Development Of A Concise, Scalable Synthesis Of A Ccr1 Antagonist Utilizing A Continuous Flow Curtius Rearrangement

Solvent- and Catalyst-Free Environmentally Benign High Hydrostatic Pressure-Assisted Synthesis of Bioactive Hydrazones and the Evaluation of Their Stability Under Various Storage Conditions

Green Method Synthesis of Pyrano[2,3-d]Pyrimidine Derivatives: Antimicrobial and Electrochemical Behavior Studies

Synthetic and Computational Studies Towards the Optimized Preparation of 1,2,4‐Triazolo[1,5‐a]pyridine‐2‐carboxylate. Advantages of Continuous Flow Processing